More articles from Chronic Kidney Disease

You have accessRestricted Access
Association between Urine Ammonium and Urine TGF-β1 in CKD
Kalani L. Raphael, Sarah Gilligan, Thomas H. Hostetter, Tom Greene and Srinivasan Beddhu

CJASN February 2018, 13 (2) 223-230; DOI: https://doi.org/10.2215/CJN.07510717

Add to Selected Citations
You have accessRestricted Access
Medication Therapy Management after Hospitalization in CKD
Katherine R. Tuttle, Radica Z. Alicic, Robert A. Short, Joshua J. Neumiller, Brian J. Gates, Kenn B. Daratha, Celestina Barbosa-Leiker, Sterling M. McPherson, Naomi S. Chaytor, Brad P. Dieter, Stephen M. Setter and Cynthia F. Corbett

CJASN February 2018, 13 (2) 231-241; DOI: https://doi.org/10.2215/CJN.06790617

Add to Selected Citations
You have accessRestricted Access
Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans
Joseph Lunyera, Clemontina A. Davenport, Nrupen A. Bhavsar, Mario Sims, Julia Scialla, Jane Pendergast, Rasheeda Hall, Crystal C. Tyson, Jennifer St. Clair Russell, Wei Wang, Adolfo Correa, L. Ebony Boulware and Clarissa J. Diamantidis

CJASN February 2018, 13 (2) 213-222; DOI: https://doi.org/10.2215/CJN.06430617

Add to Selected Citations
You have accessRestricted Access
The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD
Rakesh Malhotra, Ronit Katz, Andrew Hoofnagle, Andrew Bostom, Dena E. Rifkin, Ruth Mcbride, Jeffrey Probstfield, Geoffrey Block and Joachim H. Ix

CJASN January 2018, 13 (1) 36-44; DOI: https://doi.org/10.2215/CJN.05440517

Add to Selected Citations
Open Access
Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD
David A. Bushinsky, Thomas Hostetter, Gerrit Klaerner, Yuri Stasiv, Claire Lockey, Sarah McNulty, Angela Lee, Dawn Parsell, Vandana Mathur, Elizabeth Li, Jerry Buysse and Robert Alpern

CJASN January 2018, 13 (1) 26-35; DOI: https://doi.org/10.2215/CJN.07300717

Add to Selected Citations
You have accessRestricted Access
FGF23 and Left Ventricular Hypertrophy in Children with CKD
Mark M. Mitsnefes, Aisha Betoko, Michael F. Schneider, Isidro B. Salusky, Myles Selig Wolf, Harald Jüppner, Bradley A. Warady, Susan L. Furth and Anthony A. Portale

CJASN January 2018, 13 (1) 45-52; DOI: https://doi.org/10.2215/CJN.02110217

Add to Selected Citations
You have accessRestricted Access
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD
Sophie Liabeuf, Jean-Philippe Ryckelynck, Najeh El Esper, Pablo Ureña, Christian Combe, Bertrand Dussol, Denis Fouque, Philippe Vanhille, Luc Frimat, Eric Thervet, Romuald Mentaverri, Dominique Prié and Gabriel Choukroun; for the FRENCH Study collaborators

CJASN December 2017, 12 (12) 1930-1940; DOI: https://doi.org/10.2215/CJN.03030317

Add to Selected Citations
You have accessRestricted Access
Urinary Fibrinogen as a Predictor of Progression of CKD
Hongtian Wang, Chunxia Zheng, Yinghui Lu, Qi Jiang, Ru Yin, Ping Zhu, Minlin Zhou and Zhihong Liu

CJASN December 2017, 12 (12) 1922-1929; DOI: https://doi.org/10.2215/CJN.01360217

Add to Selected Citations
You have accessRestricted Access
Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease
Keiichi Sumida, Miklos Z. Molnar, Praveen K. Potukuchi, Koshy George, Fridtjof Thomas, Jun Ling Lu, Kunihiro Yamagata, Kamyar Kalantar-Zadeh and Csaba P. Kovesdy

CJASN December 2017, 12 (12) 1941-1949; DOI: https://doi.org/10.2215/CJN.02720317

Add to Selected Citations
You have accessRestricted Access
Metabolomic Alterations Associated with Cause of CKD
Morgan E. Grams, Adrienne Tin, Casey M. Rebholz, Tariq Shafi, Anna Köttgen, Ronald D. Perrone, Mark J. Sarnak, Lesley A. Inker, Andrew S. Levey and Josef Coresh

CJASN November 2017, 12 (11) 1787-1794; DOI: https://doi.org/10.2215/CJN.02560317

Add to Selected Citations

Main menu

User menu

Search

More articles from Chronic Kidney Disease

Pages

About

Author Information

More information